Skip to content
Disclosery

EXANE DERIVATIVES: GILD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GILD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13,537 GILD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13,537 shares
    Change vs previous 13F -4,847 shares

    0.48% of the 13F portfolio, value $836,620.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 18,384 shares
    Change vs previous 13F +3,636 shares

    0.31% of the 13F portfolio, value $1,092,936.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 14,748 shares
    Change vs previous 13F +586 shares

    0.26% of the 13F portfolio, value $1,070,887.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 14,162 shares
    Change vs previous 13F +9,521 shares

    0.25% of the 13F portfolio, value $989,255.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,641 shares
    Change vs previous 13F -1,201 shares

    0.07% of the 13F portfolio, value $315,641.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 5,842 shares
    Change vs previous 13F +493 shares

    0.11% of the 13F portfolio, value $377,586.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,349 shares
    Change vs previous 13F -15,592 shares

    0.09% of the 13F portfolio, value $311,646.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 20,941 shares
    Change vs previous 13F not available

    0.43% of the 13F portfolio, value $1,323,297.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).